Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections.

201595 citationsJournal Article

Authors

Peter P. Sordillo · SignPath Pharma (United States)

Lawrence Helson · SignPath Pharma (United States)

Abstract

The use of curcumin should be investigated in patients with Ebola and cytokine storm. Intravenous formulations may allow achievement of therapeutic blood levels of curcumin.

Topics & Keywords

RNA Interference and Gene Delivery Virus-based gene therapy research Curcumin's Biomedical Applications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 29, Issue 1, pp. 1-4

Field-Weighted Citation Impact: 2.33